APA

Cordy J. C., Morley P. J., Wright T. J., Birchler M. A., Lewis A. P., Emmins R., Chen Y. Z., Powley W. M., Bareille P. J., Wilson R., Tonkyn J., Bayliffe A. I. & Lazaar A. L. (20160315). Specificity of human anti-variable heavy (VH ) chain autoantibodies and impact on the design and clinical testing of a VH domain antibody antagonist of tumour necrosis factor-α receptor 1. : Clinical and experimental immunology.

Chicago

Cordy J C, Morley P J, Wright T J, Birchler M A, Lewis A P, Emmins R, Chen Y Z, Powley W M, Bareille P J, Wilson R, Tonkyn J, Bayliffe A I and Lazaar A L. 20160315. Specificity of human anti-variable heavy (VH ) chain autoantibodies and impact on the design and clinical testing of a VH domain antibody antagonist of tumour necrosis factor-α receptor 1. : Clinical and experimental immunology.

Harvard

Cordy J. C., Morley P. J., Wright T. J., Birchler M. A., Lewis A. P., Emmins R., Chen Y. Z., Powley W. M., Bareille P. J., Wilson R., Tonkyn J., Bayliffe A. I. and Lazaar A. L. (20160315). Specificity of human anti-variable heavy (VH ) chain autoantibodies and impact on the design and clinical testing of a VH domain antibody antagonist of tumour necrosis factor-α receptor 1. : Clinical and experimental immunology.

MLA

Cordy J C, Morley P J, Wright T J, Birchler M A, Lewis A P, Emmins R, Chen Y Z, Powley W M, Bareille P J, Wilson R, Tonkyn J, Bayliffe A I and Lazaar A L. Specificity of human anti-variable heavy (VH ) chain autoantibodies and impact on the design and clinical testing of a VH domain antibody antagonist of tumour necrosis factor-α receptor 1. : Clinical and experimental immunology. 20160315.